Clinical Trial Update: Angiotensin-converting Enzyme Inhibitors and Early Sickle Cell Renal Disease in Children [NA]

View source ↗

Summary

This update reports on a terminated clinical trial evaluating angiotensin-converting enzyme inhibitors for early sickle cell renal disease in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Angiotensin-converting enzyme inhibitors

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Sickle Cell Disease | NA | Status: TERMINATED